Clinical Trial Update: Phase I/II Study of Nab-paclitaxel and Gemcitabine Followed by AG-mFOLFOX in Patients With Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating nab-paclitaxel and gemcitabine followed by AG-mFOLFOX in metastatic pancreatic adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• AG-mFOLFOX
• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | Conditions: Metastatic Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED